Company news
electroCore, Inc. news in 2025
electroCore, Inc.'s news releases, calls and decks from 2025, newest first.
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
December 2, 2025
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2025
electroCore Announces Third Quarter 2025 Financial Results
November 5, 2025
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
October 23, 2025
ElectroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(4)
October 6, 2025
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
October 3, 2025
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
September 30, 2025
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
September 29, 2025
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
September 22, 2025
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board
September 5, 2025
electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief
September 4, 2025
electroCore Appoints Elena Bonfiglioli to Board of Directors
September 3, 2025
electroCore to Participate at H.C. Wainwright Global Investment Conference
September 2, 2025
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga
August 12, 2025
electroCore Announces Second Quarter 2025 Financial Results
August 6, 2025
electroCore Appoints James C. Theofilos to the Board of Directors
August 5, 2025
electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025
July 23, 2025
electroCore to Participate in Upcoming Investor Conferences
July 22, 2025
electroCore Announces First Quarter 2025 Financial Results
May 7, 2025
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
May 2, 2025
electroCore’s Truvaga™ Now Works with the Apple Health app
May 1, 2025
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025
April 30, 2025
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries
April 17, 2025
electroCore to Participate at the Planet MicroCap Showcase
April 16, 2025
electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times
April 3, 2025
electroCore to Participate at the Needham Virtual Healthcare Conference
April 1, 2025
electroCore Extends VA Contract for Five Years
March 31, 2025
electroCore Announces Full Year 2024 Financial Results
March 12, 2025
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025
March 6, 2025
electroCore to Participate at Upcoming Investor Conferences
March 5, 2025
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
electroCore’s Truvaga™ Now Available on Amazon®
February 19, 2025
electroCore Expands Intellectual Property Portfolio
February 5, 2025
Calls in 2025
Decks in 2025
- Investor Presentation (January 2025)
Investor deck · 24 slides · Jan 17, 2025